Workshop on Building a Renal Denervation Program-Device Data: A Quick Recap, Dr. Syed T. Ahsan

Video Transcription

Video Summary

Dr. Syed Hassan, a vascular medicine specialist from Henry Ford Hospital, discusses his decade-long research on renal denervation (RDN) for hypertension control. He emphasizes the historical and ongoing evolution of RDN technologies, such as radiofrequency, ultrasound, and the emerging alcohol-mediated method, aimed at suppressing the sympathetic system to manage blood pressure. Initial trials like Simplicity showed promise in blood pressure reduction, but results were tempered by factors such as patient adherence and operator experience. Recent studies highlight RDN's long-term efficacy and safety, demonstrating sustained blood pressure reduction and stability in kidney function over nine years. The safety margin is strong, with minimal adverse outcomes. As RDN proves effective akin to traditional medication, it's progressively being recognized in medical guidelines. Dr. Hassan underscores the careful selection of patients and practitioners to optimize outcomes, marking RDN as a promising hypertension treatment.

Keywords

renal denervation

hypertension

blood pressure

RDN technologies

Dr. Syed Hassan